Understanding SARS-CoV-2 and Host Immune Response to COVID-19 with PacBio Sequencing
For Research Use Only. Not for use in diagnostics procedures.
© Copyright 2020 by Pacific Biosciences of California, Inc. All rights reserved.
1305 O'Brien Rd., Menlo Park, CA 94025 | Legal & Trademarks
With the COVID-19 global pandemic, there is an urgent need to advance genetic research into the novel coronavirus (SARS-CoV-2), including testing, transmission, treatment, and the immunology and epidemiology of host immune response.
Highly accurate long-read sequencing provides multiple benefits for COVID-19 research, including full-length viral RNA reference genomes for SARS-CoV-2 isolates.
Join us to hear directly from research scientists discussing these long-read sequencing applications — including methods, case study results, and new assays for SARS-CoV-2 and COVID-19 that are now under development.
Attend this webinar to understand:
- How highly accurate long reads can help with sequencing SARS-CoV-2
- Protocols for genetic mutation profiling in SARS-CoV-2 viral RNA isolates
- The advantages of long-read sequencing for BCR profiling and inference-free genotyping of the IGH locus for understanding variation in antibody-mediated immunty, which may be of relevance to the current pandemic
- Methods for imputation-free long-read sequencing of the HLA loci, highly polymorphic mediators of the human adaptive immune response that have been linked to increased resistance or susceptibility to infectious diseases
Melissa Laird-Smith, Ph.D.
Assistant Professor of Genetics and Genome Sciences
Mt. Sinai
Talk: Evaluating the Impact of Host Immune Restriction in Health and Disease with High Resolution HLA Typing
SPEAKERS:
Corey T. Watson, Ph.D.
Assistant Professor
University of Louisville School of Medicine
Talk: Overcoming Complexity to Elucidate the Role of IGH Haplotype Diversity in Antibody-mediated Immunity
Director, Market Strategy for Microbial and Cancer Genomics
PacBio
HOSTED BY